Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03632317
Recruitment Status : Withdrawn (low accrual)
First Posted : August 15, 2018
Last Update Posted : August 19, 2019
Sponsor:
Information provided by (Responsible Party):
University of Michigan Rogel Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 2025
Estimated Study Completion Date : October 2025